Cytokinetics ( NASDAQ:CYTK – Get Rating ) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.38) EPS for the quarter, missing analysts' consensus estimates of ($1.24) by ($0.14), Briefing.com reports. Cytokinetics had a negative net margin of 410.89% and a negative return on equity of 1,401.63%. The firm had revenue of $4.60 million during the quarter, compared to analysts' expectations of $2.50 million. During the same period in the prior year, the company posted ($1.

https://www.dailypolitical.com/2023/05/05/cytokinetics-nasdaqcytk-releases-earnings-results.html

#dailypolitical